New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 28, 2014
11:08 EDTWB, SHLD, WUBA, AZN, MACK, DB, KERX, BBY, RMTI, ARUNOptions with decreasing implied volatility
Options with decreasing implied volatility: KERX WUBA ARUN DB SHLD RMTI MACK WB BBY AZN
News For KERX;WUBA;ARUN;DB;SHLD;RMTI;MACK;WB;BBY;AZN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
April 13, 2015
08:58 EDTAZNMerck may have positive read through from briefing docs, says SunTrust
Subscribe for More Information
08:54 EDTAZNAstraZeneca has negative read through from briefing docs, says SunTrust
Subscribe for More Information
08:17 EDTARUNAruba Networks selected by Boston Medical Center for app solutions
Aruba Networks announced that Boston Medical Center, a private, not-for-profit, 482-bed, academic medical center in Boston, MA., is deploying Aruba’s 802.11ac and mobile app solutions to enable a campus-wide Gigabit wireless network with indoor location services that will benefit physicians, staff and patients.
06:35 EDTSHLDSears volatility low into Simon Property a joint venture of real estate holdings
Subscribe for More Information
06:22 EDTSHLDGap, Target, others scrutinized by NY AG over staffing practices, WSJ says
Several major retailer including Gap (GPS) and Target (TGT) are under investigation by New York Attorney General Eric Schneiderman over their staffing practices and whether they require workers to show up or stay home with little notice, The Wall Street Journal reports. Schneiderman sent letters warning Abercrombie & Fitch (ANF), JC Penney (JCP), Urban Outfitters (URBN), TJX Cos (TJX), Ann Inc (ANN), L Brands (LB), Burlington Stores (BURL), Sears Holdings (SHLD), Williams-Sonoma (WSM) and J Crew Group that he believes the chains are using on-call scheduling and that such practices may be in violation of New York laws. Reference Link
06:06 EDTSHLDSears, Simon Property form 50/50 JV
Subscribe for More Information
April 10, 2015
10:36 EDTAZNAstraZeneca trades lower, levels to watch
Shares are down less than 1% to $69.54 at time of writing. At that price the stock is just above the 50-day moving average at $69.12. Since May of last year, price has oscillated around the 50-day, with the average acting as the approximate center line. Support below the 50-day is at $68.24.
10:07 EDTMACKHigh option volume stocks
Subscribe for More Information
09:25 EDTAZNFDA staff say analysis suggests Onglyza may increase risk of death
Subscribe for More Information
06:38 EDTWBChina using new weapon to censor Internet content, NY Times says
China has deployed a new weapon in its effort to prevent Chinese citizens from viewing foreign websites of which Beijing does not approve, according to The New York Times. Dubbed The Great Cannon, the new weapon enables the government to intercept foreign web traffic flowing to Chinese websites, inject malicious code, and redirect the traffic, the newspaper stated, adding that the technology could easily be used to spy on all users who obtain content hosted on a Chinese computer. Chinese Internet stocks include Baidu (BIDU), SINA (SINA), Wiebo (WB), and Sohu.com (SOHU). Reference Link
April 9, 2015
16:58 EDTDBDeutsche Bank close to deal in LIBOR case, NYT reports
Subscribe for More Information
16:54 EDTDBDeutsche Bank close to deal in LIBOR case, NYT reports
Subscribe for More Information
11:11 EDTWBOptions with increasing implied volatility
Options with increasing implied volatility: TLM WETF GRPN TRIP GMCR MYL AOL WB WFM EA
09:25 EDTAZNPiper Jaffray pharmaceuticals analysts hold an analyst/industry conference call
Subscribe for More Information
09:18 EDTBBYBofA/Merrill retail analysts hold an analyst/industry conference call
Subscribe for More Information
April 8, 2015
06:06 EDTAZNInovio selected by DARPA to lead $45M Ebola prevention program
Subscribe for More Information
April 7, 2015
16:12 EDTAZNRegulus up 5% after RG-125 selected as clinical candidate by AstraZeneca
Subscribe for More Information
16:12 EDTAZNRegulus RG-125 selected as clinical candidate by AstraZeneca
Regulus Therapeutics (RGLS) announced the selection of RG-12, a GalNAc-conjugated anti-miR targeting microRNA-103/107, or miR-103/107, for the treatment of Non Alcoholic Steatohepatitis, or NASH, in patients with type 2 diabetes/pre-diabetes, as a clinical candidate by AstraZeneca (AZN) under the companies' strategic alliance to discover, develop and commercialize microRNA therapeutics. RG-125 is the first compound from the alliance to be selected for clinical development by AstraZeneca. In connection with the candidate selection, AstraZeneca will pay Regulus $2.5M and will assume development of the program following acceptance of an Investigational New Drug application. In the near term, Regulus and AstraZeneca plan to submit key preclinical data on the RG-125 program to be presented at a scientific meeting later this year and expect to initiate a Phase I study of RG-125 in humans by the end of 2015.
07:14 EDTAZNEyeforpharma to hold a summit
Philadelphia 2015 Commercial Pharma Summit is being held in Philadelphia on April 7-8.
April 6, 2015
16:31 EDTDBDeutsche Bank begins talks to sell Plenary Group stake, AFR says
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use